Article
Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine development
2022-03-11
Abstract excerpt
<h4>Background: </h4> Bladder cancer (BLCA) is a common malignancy from urinary tract. Although the diagnosis and treatment of bladder cancer has made great progress in the past few decades, the effects of existing treatment methods are still limited. Therefore, it is still necessary to develop new methods to assist in the disease management and treatment. Tumor antigens are tumor-specific surface molecules and ar...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aef9fd61-2b24-59a4-87b8-3e53d3656f50
- DOI
- 10.21203/rs.3.rs-1433880/v1
